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METOCLOPRAMIDE has been used in the treatment of various gastro-intestinal
disorders for over a decade. Dystonic reactions to metoclopramide have been
reported previously by Casteels-Van Daele et al (1970) and also Witzel (1968). The
symptoms of dystonia appeared in their patients following the administration of
metoclopramide in doses exceeding 0.5 mg/kg body weight for longer than a
24-hour period.
CASE REPORTS
Case 1: A girl, aged two and a half years and weighing 14 kg was admitted with a
history of constipation and vomiting for five days prior to admission. She had
been given a single dose of 5 ml (5 mg) of metoclopramide syrup. One hour later
she became dysarthic and also dysphagic. The whole episode lasted for one hour.
She was admitted to hospital for observation and remained well and was discharged
24 hours later.
Case 2: A girl, aged three and a half months and weighing 5 kg was admitted to
hospital wiith a 48-hour history of diarrhoea and two episodes of vomiting. She
had been given 2 ml (2 mg) of metoclopramide syrup. Forty-five minutes after
administration of metoclopramide she suddenly had an oculogyric crisis and
persisting head retraction. On admission to hospital she had head retraction and
a general increase in muscle tone. The whole episode lasted for half-an-hour and
then recurred more briefly two hours later. She had no further spasms after this
and was discharged 48 hours later from hospital.
Case 3: A boy, aged ten years and six months and weighing 36 kg was admitted
to hospital with a history of a flu-like illness and vomiting for the previous 48 hours.
He had been treated with metoclopramide 5 mg eight hourly for the previous 48
hours. He suddenly became dysarthic and developed a left-sided torticollis. His
fingers became stiff and he was unable to grasp objects. The whole episode lasted
one and a half hours. After admission to hospital he had no further spasms and he
was discharged 48 hours later.
Case 4: A girl, aged eleven months and weighing 11 kg was admitted with a history
of a diarrhoeal illness for 24 hours and had also vomited on five occasions over
the same period. She had been given 2.5 ml (2.5 mg) of metoclopramide syrup and
five hours after this she had a brief respiratory arrest and then persisting upward
deviation of her eyes lasting five to ten minutes. After admission to hospital she
remained well and was discharged 48 hours later.
Case 5: A girl, aged nine and a half years and weighing 34 kg was admitted with
a 48 hour history of abdominal pain but no vomiting or diarrhoea. She had been
treated at home with metoclopramide tablets 5 mg twice a day in the first 24 hour
38period and then three times a day in the second 24 hour period. She suddenly
developed spinal torsion and an associated right-sided torticollis. She became
exceedingly frightened and also was dysarthric. The spasms fluctuated, lasting 10 to
15 minutes over one and a half hour period, and then did not recur again.
None of the above children had evidence of dehydration nor had they any
personal or family history of epilepsy.
DISCUSSION
Metoclopramide has been described as having two sites of action (Drug &
Therapeutic's Bulletin, 1976). It firstly increases the peristalic activity of the upper
parts of the upper intestine. It has been suggested that this is caused by antagonism
of a purinergic relaxation system in the intestine. Its effect in causing rapid gastric
emptying has lead to its use in the treatment of gastro-intestinal disorders, and also
radiological investigations particularly in adults and in children for jejunal biopsy
procedures. The drug secondly, has an effect on the central nervous system by
blocking dopaminergic reactions which in themselves may lead to nausea and
vomiting. It has been suggested, however, (Drug & Therapeutic's Bulletin, 1976)
that metoclopramide may block the dopaminergic functions at low doses while only
causing disturbances of movement or muscle tone at higher doses. It has previously
been suggested that dystonic reactions should not occur in patients receiving less
than 0.5 mg/kg body weight of metoclopramide. (Robinson, 1973; Committee on
Safety of Medicines, 1975). However, in our patients the amount of the drug per
kilogram was less than 0.5 mg/kg body weight, varying between 0.36 to 0.44 mg/kg
of body weight. Moreover, three of the five children developed reactions within six
hours of having a single dose of the drug. All the children appeared to be frightened
by the reaction and their parents were also upset assuming that the children might
have had an epileptic fit or in one case a stroke. All our cases occurred over a
period of eighteen months in a paediatric population of approximately 40,000. We
have had anecdotal reports of other cases having occurred at home but these have
either been milder or have been treated by their own general practitioner. It would
seem, therefore, the incidence of reaction may have been somewhat higher than
is generally appreciated. We would, therefore, suggest that metoclopramide is used
cautiously in children and its use be reserved for those children who have persistent
vomiting, rather than being prescribed more non-specifically in the treatment of
abdominal pain, or diarrhoea as at present apparently occurs. We also suggest that
a smaller dose should be prescribed than is presently recommended, and considera-
tions be given to the use of other anti-emetic drugs. Lastly, parents should be
warned in advance, that dystonic reactions may occasionally occur following the
use of metoclopramide.
SUMMARY
Five cases of dystonic reactions following oral administration of metoclopramide
are described. These reactions occurred over an eighteen month period in a
paediatric population of 40,000. The reactions occurred despite the fact the drug
was administered in the suggested therapeutic quantity. The reactions lasted from
39five to forty-five minutes and varied in severity from a brief respiratory arrest to
dystharia and torticollis. We therefore suggest that the drug be prescribed in
smaller amounts than previously suggested, and parents are warned of the possi-
bility of reaction which may occur after administration.
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